학술논문
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
Document Type
Article
Author
Source
In Annals of Oncology June 2018 29(6):1409-1416
Subject
Language
ISSN
0923-7534